Our study demonstrated that the prevalence of rs35829419 (Q705K, NLRP3) polymorphism is higher in subjects with pancreatic cancer and that of rs17699678 (F359L, NLRP2) polymorphism is higher in the group of chronic pancreatitis. This evidence concerns the gene NLRP3 and chronic pancreatitis.